Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neo-adjuvant Abiraterone Acetate and GnRH Agonist in High Risk Localised Prostate Carcinoma
NCT02160353Phase 2Completed
- Sponsor
- Cancer Trials Ireland
- Start
- Jul 2015
- Primary completion
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of abiraterone in prostate carcinoma, sponsored by Cancer Trials Ireland. Started Jul 2015; status: completed.
02
Drugs
abiraterone
03
Conditions
prostate carcinoma
Beyond the preview
Go deeper on NCT02160353.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02160353.